-- 
Lilly, Boehringer Win U.S. Approval for Type 2 Diabetes Drug

-- B y   M o l l y   P e t e r s o n
-- 
2011-05-02T18:59:49Z

-- http://www.bloomberg.com/news/2011-05-02/lilly-boehringer-win-u-s-approval-for-type-2-diabetes-drug.html
Eli Lilly & Co. (LLY)  and Boehringer
Ingelheim GmbH won U.S. approval of a new drug to improve blood
glucose control in people with Type 2 diabetes.  The drug, linagliptin, was shown to be safe and effective
in eight clinical studies involving about 3,800 patients with
Type 2 diabetes, the most common form of the disease, the  Food
and Drug Administration  said today in a statement.  To contact the reporter on this story:
Molly Peterson in Washington at 
 mpeterson9@bloomberg.net   To contact the editor responsible for this story:
Adriel Bettelheim at 
 abettelheim@bloomberg.net . 